Zobrazeno 1 - 10
of 209
pro vyhledávání: '"Michael R Loebinger"'
Autor:
Adam T Hill, Michael R Loebinger, Lizzie Grillo, Kevin Gruffydd-Jones, Karen Payne, Anita Sullivan, Miguel Souto, James Wildgoose
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
This British Thoracic Society Quality Standard for Clinically Significant Bronchiectasis in Adults 2022 aims to encourage good practice by setting standards of high-quality respiratory care that services should follow.
Externí odkaz:
https://doaj.org/article/a764935e0b10412f84eaa103e693e413
Autor:
Steven A Cowman, Phillip James, Robert Wilson, William O C Cookson, Miriam F Moffatt, Michael R Loebinger
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208018 (2018)
The diagnosis of pulmonary non-tuberculous mycobacterial disease (pNTM) is dependent on the isolation of NTM in culture, which is prone to overgrowth and contamination and may not capture the diversity of mycobacteria present, including rare or unide
Externí odkaz:
https://doaj.org/article/df4214ce644b497b99669afcad768f72
Autor:
Michael J Cox, Elena M Turek, Catherine Hennessy, Ghazala K Mirza, Phillip L James, Meg Coleman, Andrew Jones, Robert Wilson, Diana Bilton, William O C Cookson, Miriam F Moffatt, Michael R Loebinger
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0170622 (2017)
BACKGROUND:Bronchiectasis is accompanied by chronic bronchial infection that may drive disease progression. However, the evidence base for antibiotic therapy is limited. DNA based methods offer better identification and quantification of microbial co
Externí odkaz:
https://doaj.org/article/e8c2345d2df24e73b5d786c88430113e
Autor:
Stefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, Andrea Calcagno, Andreas Fløe, Dorothy Grogono, Apostolos Papavasileiou, Eva Polverino, Concepción Prados, Gernot Rohde, Helmut J.F. Salzer, Adrián Sánchez-Montalvá, Michal Shteinberg, Eva Van Braeckel, Jakko van Ingen, Nicolas Veziris, Dirk Wagner, Michael R. Loebinger
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/1e2b4d6d776d48a4bdf26d372de88ca1
Autor:
Renate Kos, Myrofora Goutaki, Helene E. Kobbernagel, Bruna Rubbo, Amelia Shoemark, Stefano Aliberti, Josje Altenburg, Pinelopi Anagnostopoulou, Rodrigo A. Athanazio, Nicole Beydon, Sharon D. Dell, Nagehan Emiralioglu, Thomas W. Ferkol, Michael R. Loebinger, Natalie Lorent, Bernard Maître, June Marthin, Lucy C. Morgan, Kim G. Nielsen, Felix C. Ringshausen, Michal Shteinberg, Harm A.W.M. Tiddens, Anke H. Maitland-Van der Zee, James D. Chalmers, Jane S.A. Lucas, Eric G. Haarman
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Background Consistent use of reliable and clinically appropriate outcome measures is a priority for clinical trials, with clear definitions to allow comparability. We aimed to develop a core outcome set (COS) for pulmonary disease interventions in pr
Externí odkaz:
https://doaj.org/article/206a1713eedc40ba92a771037176fcd8
Publikováno v:
European Respiratory Review, Vol 31, Iss 163 (2022)
Nontuberculous mycobacterial pulmonary disease (NTM-PD) remains a challenging condition to diagnose and treat effectively. Treatment of NTM-PD is prolonged, frequently associated with adverse effects and has variable success. In this review, we consi
Externí odkaz:
https://doaj.org/article/122af0c2ad194141bd3fe14bc292097a
Publikováno v:
ERJ Open Research, 9, 3
ERJ Open Research, 9
ERJ Open Research, 9
BackgroundCertain patients are at greater risk of developing nontuberculous mycobacterial pulmonary disease (NTM-PD), including those with lung conditions such as bronchiectasis. Testing for nontuberculous mycobacteria (NTM) in patients at risk is ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ff4ffcb3b4fa69b7206ab955dce8e8
https://doi.org/10.1183/23120541.00737-2022
https://doi.org/10.1183/23120541.00737-2022
Autor:
Huw C. Ellis, Miriam F. Moffatt, Colin Churchward, Leah Cuthbertson, William O.C. Cookson, Michael R. Loebinger
Publikováno v:
ERJ Open Research. 9:00435-2022
IntroductionNontuberculous pulmonary disease causes significant morbidity and mortality. Efforts to tackle infections are hampered by the lack of reliable biomarkers for diagnosis, assessment and prognostication. The aim of this study was to develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e14fb78bb1c19d61a4c0046b0b86ceae
https://doi.org/10.1183/23120541.00435-2022
https://doi.org/10.1183/23120541.00435-2022
Autor:
Katherine O’Neill, Gokul R. Lakshmipathy, Curtis Neely, Denise Cosgrove, Kathryn Ferguson, Rebecca McLeese, Adam T. Hill, Michael R. Loebinger, Mary Carroll, James D. Chalmers, Timothy Gatheral, Chris Johnson, Anthony De Soyza, John R. Hurst, Ian Bradbury, Joseph S. Elborn, Judy M. Bradley
Publikováno v:
O'Neill, K, Lakshmipathy, G R, Neely, C, Cosgrove, D, Ferguson, K, McLeese, R, Hill, A T, Loebinger, M R, Carroll, M P, Chalmers, J D, Gatheral, T, Johnson, C, de Soyza, A, Hurst, J R, Bradbury, I, Elborn, J S & Bradley, J M 2022, ' Multiple breath washout outcome measures in adults with bronchiectasis ', Annals of the American Thoracic Society, vol. 19, no. 9, pp. 1489-1497 . https://doi.org/10.1513/AnnalsATS.202006-584OC
Ann Am Thorac Soc
Ann Am Thorac Soc
RATIONALE: Lung clearance index (LCI) has good intravisit repeatability with better sensitivity in detecting lung disease on computed tomography scan compared with forced expiratory volume in 1 second (FEV(1)) in adults with bronchiectasis. Alternati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330706feaeadf0af46e51d825d3c7e02
https://doi.org/10.1513/annalsats.202006-584oc
https://doi.org/10.1513/annalsats.202006-584oc
Autor:
James D Chalmers, Eva Polverino, Megan L Crichton, Felix C Ringshausen, Anthony De Soyza, Montserrat Vendrell, Pierre Régis Burgel, Charles S Haworth, Michael R Loebinger, Katerina Dimakou, Marlene Murris, Robert Wilson, Adam T Hill, Rosario Menendez, Antoni Torres, Tobias Welte, Francesco Blasi, Josje Altenburg, Michal Shteinberg, Wim Boersma, J Stuart Elborn, Pieter C Goeminne, Stefano Aliberti
Publikováno v:
EMBARC Registry Investigators 2023, ' Bronchiectasis in Europe : data on disease characteristics from the European Bronchiectasis registry (EMBARC) ', The Lancet Respiratory Medicine, vol. 11, no. 7, pp. 637-649 . https://doi.org/10.1016/S2213-2600(23)00093-0
Background: Bronchiectasis is a heterogeneous, neglected disease with few multicentre studies exploring the causes, severity, microbiology, and treatment of the disease across Europe. This aim of this study was to describe the clinical characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79b73767457060be6a35ebc0cc085b1
https://doi.org/10.1016/s2213-2600(23)00093-0
https://doi.org/10.1016/s2213-2600(23)00093-0